Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
- Status
- COMPLETED
- Phase
- PHASE4
Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications
- Status
- COMPLETED
- Phase
- N/A
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study
- Status
- COMPLETED
- Phase
- PHASE4
To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia
- Status
- COMPLETED
- Phase
- PHASE4
Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients
- Status
- COMPLETED
- Phase
- PHASE2